Biopharma firm BioXcel Therapeutics files for bankruptcy in US

AI-driven biopharma firm BioXcel Therapeutics filed for Chapter 11 bankruptcy protection ​in the U.S. on Thursday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。